NASDAQ:ANTX

AN2 Therapeutics, Inc.

Stock

USD

Last Close

2.64

26/07 20:00

Market Cap

77.56M

Beta: -

Volume Today

38.87K

Avg: 25.23K

PE Ratio

−8.83

PFCF: −13.99

Overview Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Biotechnology
website
www.an2therapeutics.com
ipo date
Mar 25, 2022

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.

peer of

Earnings

Earnings Release in 12 days

Earnings per Share (Estimate*)

Revenue (Estimate*)

*Estimate based on analyst consensus